Fine on errant ‘Modicare’ insurers

NEW DELHI: The government has introduced tough penal provisions for delay in settlement of insurance claims under its ambitious Ayushman Bharat National Health Protection Scheme (NHPS). Insurance companies may have to pay a hefty penalty as interest to hospitals for delay in payment under the scheme.

According to the model tender document, if claim payment is delayed beyond 15 days, insurance companies will pay a penalty of 1% interest on the claimed amount per week. This will be paid directly by the insurer to the hospital. In case of inter-state claims or portability of benefits, the penalty will become due after 30 days.

Similar penal provisions are also applicable to state health agencies and even on the Centre if they fail to deposit their share of premium to the escrow account or release payments to insurers on time.

The health insurance scheme, popularly known as Modicare, aims to cover nearly 50 crore beneficiaries from over 10.74 crore “deprived” families as per the socio-economic and caste census (SECC) data with an annual health cover of Rs 5 lakh per family per year.

Timely payments have been a major area of concern for healthcare providers. In order to streamline the payment mechanism and avoid delays similar to the Central Government Health Scheme (CGHS), the government has fixed specific time-lines for releasing payments against claims made under the scheme.

Payments to insurers will be released in three different tranches by the state health agencies from a designated escrow account. The Centre and different state governments will deposit their respective premiums into the designated escrow account.

While a hospital can complain to the state health agency if payments are not made on time, the scheme also has a grievance redressal mechanism for insurers if timely payments are not released to them.

Apart from the payment mechanism, the model tender document also details the procedures and packages covered under the scheme as well as those which are not covered and the ones which require pre-authorisation.

For instance, dental procedures, congenital external diseases, vaccinations and fertility-related procedures, along with any ailment or condition that can be treated under outpatient care or OPD will not be covered under the government-run insurance scheme. The scheme will also not cover a person who has attempted suicide or self injury.

While packages covered under the scheme include pre-hospitalisation and post hospitalisation coverage along with drugs, diagnostics and food for patient, the scheme will not cover any out- patient diagnostics and vitamins etc.

Moreover, pre-authorisation is mandated for key procedures including all packages under oncology, cardiology, cardiac surgery and opthalmology. In case of inter-state portability also, pre-authorisation is mandatory.

For administration of the scheme, the tender document divides states into two categories. Category A includes Arunachal, Goa, Himachal, J&K, Manipur, Meghalaya, Mizoram, Nagaland, NCT Delhi, Sikkim, Tripura, Uttarakhand, Andaman and Nicobar Islands, Chandigarh, Dadra and Nagar Haveli, Daman and Diu, Lakshadweep and Puducherry. Category B includes Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Jharkhand, Karnataka, Kerala, MP, Maharashtra, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, UP, and West Bengal.

  • Related Posts

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    The court left the food regulator free to pass a fresh order after issuing a show-cause notice to the company and giving it a hearing. New Delhi: The Delhi High…

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Chief Minister Nayab Singh Saini also set a 1 November deadline for opening Amrit Pharmacies in every government hospital in the state. Chandigarh: Government hospitals in Haryana will be allowed…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources